Tevogen Bio
Mittul Mehta is a seasoned technology executive currently serving as the CIO and Head of Tevogen AI at Tevogen Bio, a clinical-stage specialty immunotherapy company since October 2023. With a focus on developing precision T cell therapies through the ExacTcellTM technology platform, Mittul aims to address significant unmet medical needs in various diseases. Prior experience includes senior leadership roles at Jefferies, Avanade, and MetLife, as well as technical positions at Macy's, Microsoft, and a consultancy role at DS-NY. Mittul holds a degree from Columbia Business School, completed in September 2022.
This person is not in any teams
This person is not in any offices
Tevogen Bio
2 followers
Tevogen Bio brings together a highly skilled team of preeminent scientists, senior biopharmaceutical leaders, and manufacturing experts with the goal of advancing global health. The company’s patient-centric mission is to leverage its proprietary cell and gene therapy platforms and novel business model to rapidly innovate breakthrough immunotherapies for cancers and viral infections with high unmet needs. Tevogen Bio’s foundational vision is a healthier world through equitable access to life-saving innovations.